Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamel Abdennbi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|January 20, 2005
[Smoking in teenagers: a priority issue]Kamel Abdennbi
Revue De L'Infirmiere|October 17, 2002
[Preventive and educational role of the nurse in cardiac rehabilitation]Dominique Serpaud, Kamel Abdennbi
Panminerva Medica|October 12, 2022
Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practicePierre Sabouret, Etienne Puymirat, Serge Kownator, et al.
Panminerva Medica|April 6, 2023
French expert group proposal for lipid-lowering therapy in the first 3 months after acute myocardial infarctionFrançois Schiele, Pierre Sabouret, Etienne Puymirat, et al.
Cardiovascular Drugs and Therapy|October 3, 2008
Effect of an educational program (PEGASE) on cardiovascular risk in hypercholesterolaemic patientsEric Bruckert, Philippe Giral, François Paillard, et al.
Journal of Epidemiology and Community Health|July 17, 2007
European smokefree class competition: a measure to decrease smoking in youthReiner Hanewinkel, Gudrun Wiborg, Kamel Abdennbi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|January 20, 2005
[Smoking in teenagers: a priority issue]Kamel Abdennbi
Revue De L'Infirmiere|October 17, 2002
[Preventive and educational role of the nurse in cardiac rehabilitation]Dominique Serpaud, Kamel Abdennbi
Panminerva Medica|October 12, 2022
Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practicePierre Sabouret, Etienne Puymirat, Serge Kownator, et al.
Panminerva Medica|April 6, 2023
French expert group proposal for lipid-lowering therapy in the first 3 months after acute myocardial infarctionFrançois Schiele, Pierre Sabouret, Etienne Puymirat, et al.
Cardiovascular Drugs and Therapy|October 3, 2008
Effect of an educational program (PEGASE) on cardiovascular risk in hypercholesterolaemic patientsEric Bruckert, Philippe Giral, François Paillard, et al.
Journal of Epidemiology and Community Health|July 17, 2007
European smokefree class competition: a measure to decrease smoking in youthReiner Hanewinkel, Gudrun Wiborg, Kamel Abdennbi, et al.
Pageof 1